Mechanisms of Reovirus Bloodstream Dissemination

呼肠孤病毒血流传播机制

基本信息

  • 批准号:
    8190233
  • 负责人:
  • 金额:
    $ 16万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-07-02 至 2014-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The objective of the proposed research is to determine mechanisms by which mammalian reovirus nonstructural protein s1s promotes systemic viral dissemination. Previous studies and preliminary data indicate that the s1s protein functions in reovirus- induced cell cycle arrest and apoptosis. However, it is not known whether these processes are responsible for s1s-mediated reovirus spread in the infected host. The central hypothesis of these studies is that the s1s protein inhibits host cell cycle progression, leading to apoptotic cell death. Subsequently, apoptotic cells are engulfed by phagocytic cells that transport the virus from the site of inoculation to peripheral organs that support secondary viral replication. Two integrated specific aims are proposed to determine how s1s contributes to reovirus-induced cell cycle arrest, apoptosis, and systemic spread. The first specific aim will define sequences in s1s required for cell cycle perturbation and apoptosis induction, and identify cellular factors involved in disrupting cell cycle progression in response to reovirus infection. The second specific aim will determine the role of s1s-mediated cell cycle arrest and apoptosis in systemic reovirus dissemination in vivo. Collectively, these studies will contribute broadly to viral pathogenesis research by enhancing an understanding of the molecular and cellular bases of viral dissemination, and provide important new insights into mechanisms by which viral infection modulates the host cell cycle and culminates in disease. My near-term career goal is to obtain a position at a college or university where I will lead my own research team. I am currently applying for academic positions and hope to attain a suitable opportunity within the next academic year. I look forward to becoming an independent investigator and building my research team. I will begin by applying for research grants, including an investigator-initiated R01 application. This application for a K22 career development award has been submitted to improve the prospects of achieving both of these goals. The training I have received to this point in my career has prepared me well for the transition from postdoctoral fellow to independent laboratory team leader. This award would enhance the possibility of obtaining a tenure-track faculty position and provide funds to generate preliminary data that will form the foundation of future grant applications. Public Health Relevance: The goal of the experiments described in this proposal is to determine how cell cycle arrest and apoptosis mediated by the reovirus s1s protein contribute to viral pathogenesis. Findings from these studies could lead to new insights into these processes that play fundamental roles in development, immunity, and cancer. Such insights might lead to new treatments for degenerative, immunologic, or neoplastic diseases.
描述(由申请人提供):拟议研究的目的是确定哺乳动物呼肠孤病毒非结构蛋白 s1s 促进系统性病毒传播的机制。先前的研究和初步数据表明,s1s 蛋白在呼肠孤病毒诱导的细胞周期停滞和细胞凋亡中发挥作用。然而,尚不清楚这些过程是否导致 s1s 介导的呼肠孤病毒在受感染宿主中的传播。这些研究的中心假设是 s1s 蛋白抑制宿主细胞周期进程,导致细胞凋亡。随后,凋亡细胞被吞噬细胞吞噬,吞噬细胞将病毒从接种部位转运到支持二次病毒复制的外周器官。提出了两个综合的具体目标来确定 s1s 如何促进呼肠孤病毒诱导的细胞周期停滞、细胞凋亡和全身传播。第一个具体目标是定义细胞周期扰动和细胞凋亡诱导所需的 s1 序列,并识别响应呼肠孤病毒感染而破坏细胞周期进程的细胞因子。第二个具体目标将确定 s1s 介导的细胞周期停滞和细胞凋亡在体内系统性呼肠孤病毒传播中的作用。总的来说,这些研究将通过增强对病毒传播的分子和细胞基础的理解,为病毒发病机制研究做出广泛贡献,并为病毒感染调节宿主细胞周期并最终导致疾病的机制提供重要的新见解。我的近期职业目标是在学院或大学获得一个职位,在那里我将领导自己的研究团队。我目前正在申请学术职位,并希望在下一学年获得合适的机会。我期待成为一名独立研究者并建立我的研究团队。我将首先申请研究资助,包括研究者发起的 R01 申请。提交 K22 职业发展奖申请是为了改善实现这两个目标的前景。我职业生涯到目前为止所接受的培训为我从博士后研究员到独立实验室团队负责人的转变做好了充分的准备。该奖项将提高获得终身教授职位的可能性,并提供资金来生成初步数据,这些数据将为未来的拨款申请奠定基础。 公共卫生相关性:本提案中描述的实验的目标是确定呼肠孤病毒 s1s 蛋白介导的细胞周期停滞和细胞凋亡如何促进病毒发病机制。这些研究的结果可能会对这些在发育、免疫和癌症中发挥重要作用的过程产生新的见解。这些见解可能会带来退行性、免疫或肿瘤疾病的新疗法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Karl W Boehme其他文献

Karl W Boehme的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Karl W Boehme', 18)}}的其他基金

Reovirus induction of host inflammatory responses
呼肠孤病毒诱导宿主炎症反应
  • 批准号:
    10726153
  • 财政年份:
    2023
  • 资助金额:
    $ 16万
  • 项目类别:
Mechanisms of Reovirus Bloodstream Dissemination
呼肠孤病毒血流传播机制
  • 批准号:
    9754570
  • 财政年份:
    2016
  • 资助金额:
    $ 16万
  • 项目类别:
Mechanisms of Reovirus Bloodstream Dissemination
呼肠孤病毒血流传播机制
  • 批准号:
    9237383
  • 财政年份:
    2016
  • 资助金额:
    $ 16万
  • 项目类别:
Mechanisms of Reovirus Bloodstream Dissemination
呼肠孤病毒血流传播机制
  • 批准号:
    8502612
  • 财政年份:
    2012
  • 资助金额:
    $ 16万
  • 项目类别:
Characterization of the reovirus simga 1s protien.
呼肠弧病毒 simga 1s 蛋白的表征。
  • 批准号:
    7485441
  • 财政年份:
    2008
  • 资助金额:
    $ 16万
  • 项目类别:
Project 4 - TLR2-mediatecl control of inflammatory arthritis
项目 4 - TLR2 介导炎症性关节炎的控制
  • 批准号:
    8523931
  • 财政年份:
  • 资助金额:
    $ 16万
  • 项目类别:
Project 4 - TLR2-mediatecl control of inflammatory arthritis
项目 4 - TLR2 介导炎症性关节炎的控制
  • 批准号:
    8460762
  • 财政年份:
  • 资助金额:
    $ 16万
  • 项目类别:
Project 4 - TLR2-mediatecl control of inflammatory arthritis
项目 4 - TLR2 介导控制炎症性关节炎
  • 批准号:
    8652487
  • 财政年份:
  • 资助金额:
    $ 16万
  • 项目类别:

相似国自然基金

Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
  • 批准号:
    30801055
  • 批准年份:
    2008
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
  • 批准号:
    BB/Y006224/1
  • 财政年份:
    2024
  • 资助金额:
    $ 16万
  • 项目类别:
    Research Grant
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
  • 批准号:
    10083718
  • 财政年份:
    2023
  • 资助金额:
    $ 16万
  • 项目类别:
    Small Business Research Initiative
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
  • 批准号:
    480030
  • 财政年份:
    2023
  • 资助金额:
    $ 16万
  • 项目类别:
    Operating Grants
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
  • 批准号:
    MR/X009254/1
  • 财政年份:
    2023
  • 资助金额:
    $ 16万
  • 项目类别:
    Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
  • 批准号:
    22KJ1758
  • 财政年份:
    2023
  • 资助金额:
    $ 16万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
  • 批准号:
    BB/Y000927/1
  • 财政年份:
    2023
  • 资助金额:
    $ 16万
  • 项目类别:
    Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
  • 批准号:
    10795212
  • 财政年份:
    2023
  • 资助金额:
    $ 16万
  • 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
  • 批准号:
    23K18249
  • 财政年份:
    2023
  • 资助金额:
    $ 16万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
  • 批准号:
    10735075
  • 财政年份:
    2023
  • 资助金额:
    $ 16万
  • 项目类别:
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
  • 批准号:
    10645989
  • 财政年份:
    2023
  • 资助金额:
    $ 16万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了